Interstitial Lung Disease Associated with Chemotherapy Treatment of Metastatic Adenocarcinoma of Colon

Devendra Pal

doi:10.4103/ijmpo.ijmpo_23_18

Indian Journal of Medical and Paediatric Oncology, Table of Contents

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2019; 40(02): 298-300
DOI: 10.4103/ijmpo.ijmpo_23_18

Letter to Editor

Interstitial Lung Disease Associated with Chemotherapy Treatment of Metastatic Adenocarcinoma of Colon

Devendra Pal

Department of Medical Oncology, Dr Babasaheb Ambedkar Memorial Hospital, Central Railway (HQ), Mumbai, Maharashtra, India

› Author Affiliations

Abstract

Full Text

References

References
1 André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T. et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350: 2343-51
2 André T, Tournigand C, Achille E, Tubiana-Mathieu N, Lledo G, Raoul Y. et al. Adjuvant treatment of colon cancer MOSAIC study's main results. Bull Cancer 2006; 93 (01) S5-9
3 Ramanathan RK, Clark JW, Kemeny NE, Lenz HJ, Gococo KO, Haller DG. et al. Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancer. J Clin Oncol 2003; 21: 2904-11
4 Pasetto LM, Monfardini S. Is acute dyspnea related to oxaliplatin administration?. World J Gastroenterol 2006; 12: 5907-8
5 Garrido M, O'Brien A, González S, Clavero JM, Orellana E. Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: Case report. Chest 2007; 132: 1997-9
6 Yagüe XH, Soy E, Marino BQ, Puig J, Fabregat MB, Colomer R. et al. Interstitial pneumonitis after oxaliplatin treatment in colorrectal cancer. Clin Transl Oncol 2006; 8: 624
7 Arévalo Lobera S, Sagastibeltza Mariñelarena N, Elejoste Echeberría I, Melé Olivé M, Egaña Otaño L, Basterretxea Badiola L. et al. Fatal pneumonitis induced by oxaliplatin. Clin Transl Oncol 2008; 10: 764-7
8 Wilcox BE, Ryu JH, Kalra S. Exacerbation of pre-existing interstitial lung disease after oxaliplatin therapy: A report of three cases. Respir Med 2008; 102: 273-9
9 Shimura T, Fuse N, Yoshino T, Minashi K, Tahara M, Doi T. et al. Clinical features of interstitial lung disease induced by standard chemotherapy (FOLFOX or FOLFIRI) for colorectal cancer. Ann Oncol 2010; 21: 2005-10
10 Vahid B, Marik PE. Pulmonary complications of novel antineoplastic agents for solid tumors. Chest 2008; 133: 528-38